Where does Intervacc AB rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Intervacc AB ranks #47,805 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Intervacc AB hold?

Intervacc AB holds 5 US utility patents granted between 2016 and 2023, spanning 3 technology areas.

What is Intervacc AB's Innovation Score?

Intervacc AB has an Innovation Score of 30.6 out of 100 (35th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Intervacc AB focus on?

Intervacc AB's top technology area is C07K (Peptides) with 5 patents, ranking #1,584 of 3,615 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Intervacc AB's patent grant rate increasing or decreasing?

Intervacc AB's recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Intervacc AB's patents?

Intervacc AB's patents average 19.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Intervacc AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Intervacc AB

USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Intervacc ranks #47,805 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.

#47,805
of 49,997 US assignees by volume: 35th percentile
by Innovation Score (30.6/100): 19.4
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R47805 · Foreign Corporation #47,805 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #47,805/49,997
PHOTO-FINISH Interactive Skin
CPC-NARROW C07K · 3 areas
INNOV-THIN 30.6/100
CLAIMS-RICH 19.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Interactive Skin, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Intervacc’s 30.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (20%) Velocity 6.7 pts (22%) Breadth 6.1 pts (20%) Claim depth 11.6 pts (38%)

Qualcomm Incorporated · highest

85
Intervacc AB · this assignee

31
3D Lighting… · lowest

7

What this shows Intervacc's Innovation Score is 30.6/100 (35th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Intervacc?

Each dot is one of Intervacc’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Intervacc’s own 19.4 claims/patent is ABOVE the 18.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Intervacc vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Intervacc's grants concentrate

Intervacc AB is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under C07K (Peptides). By volume, Intervacc sits between Interactive Skin, Inc. and Intflow Inc..

Intervacc's three-year grant acceleration

Intervacc AB shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Interactive Skin

5
Interactive Sports

5
Interface Fluidics

5
Interject Data Sy…

5
Interwork Korea

5
Inteva Products E…

5
Inteva Products F…

5
Intflow

5
Intervacc AB ◀

5

What this shows Intervacc holds 5 patents at rank #47,694, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Intervacc

By rank, the assignees closest to #47,694 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Intervacc's primary technology class.

Intervacc's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 35th percentile higher than 35% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Intervacc AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	20.0%
2017	1	20.0%
2018	1	20.0%
2021	1	20.0%
2023	1	20.0%

Which technologies does Intervacc AB patent most?

C07K - Peptides 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Intervacc AB's patent record in context - here's where to go next.

Intervacc AB's lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #47,805 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Intervacc AB against Interactive Skin, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.